Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2593_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
67 Мб
Скачать
Figure 2-1 Bilirubin metabolism.
Plasma
https://t.me/medicina_free
(
RBC
Reticuloendothelial
System
)
®
1
Bilirubin+Iron
Globin
+
Liver
Bilirubin
©
#
Bilirubin Albumin
Bilirubin
diglucuronide
'
Urobilinogen
©
©
R
©
Urobilinogen
Kidney
Bilirubin
I
Bilirubin
diglucuronide
©
Urobilinogen
©
(
6
>
Bilirubin
[
diglucuronide
/
©
©
Intestine
,
Fecal
urobilinogen
Urine
urobilinogen
Urine
bilirubin
When bilirubin is reported by the lab, it is usually reported as total bilirubin, which consists of both conjugated and unconjugated fractions. If there is an elevation in any of the fractions, it will lead to an elevation of total bilirubin concentrations. It is important to note that with the exception of neonates, the majority of bilirubin should consist of the conjugated fraction.
61
MISCELLANEOUS TESTS
Amylase and Lipase
Amylase (reference range: 35–118 IU/L or 0.58–1.97 μkat/L) and lipase (reference range: 10–160 IU/L or 0–2.67 μkat/L) are enzymes produced by the pancreas and secreted into the duodenum to assist in the digestive process. Small amounts of both enzymes are also found in the saliva and stomach. Significantly elevated levels of either enzyme are suggestive of pancreatic damage.
Amylase is responsible for breaking down complex carbohydrates into simple sugars. Significant elevations in serum amylase are observed in patients with acute pancreatitis or pancreatic duct obstruction. Amylase levels tend to rise 6 to 48 hours after onset of the disease and usually return to normal 3 days after the acute event. In chronic pancreatitis or obstruction, amylase levels may remain elevated for longer periods. Other nonpancreatic conditions (eg, bowel perforation, biliary disease, perforated peptic ulcer, ectopic pregnancy, and mumps) can be associated with elevated serum amylase levels.
Lipase is responsible for breaking down triglycerides (TGs) into fatty acids. Elevated serum lipase levels are also suggestive of pancreatic disease and tend to be more specific for pancreatic disease than for amylase. Nonpancreatic conditions such as gallbladder disease or biliary cirrhosis can also lead to elevated lipase levels. The onset of lipase elevation is similar to that of amylase; however, lipase typically remains elevated for 5 to 7 days,
https://t.me/medicina_free
and can be useful in diagnosing patients in later stages of pancreatic disease. Narcotics (eg, morphine) can constrict the sphincter of Oddi and increase serum concentrations of both amylase and lipase.
Prostate-Specific Antigen
Reference Range: 0–4 ng/mL or 0–4 μg/L
Prostate-specific antigen (PSA) is a protease glycoprotein produced almost exclusively by prostate epithelial cells. Large quantities of PSA are carried in semen; only low levels are found in the blood. Serum concentrations of PSA are increased when the normal prostate glandular structure is disrupted by benign or malignant tumor or inflammation (prostatitis). More than half of males with benign prostatic hyperplasia (BPH) have elevated serum PSA concentrations. PSA is also a valuable parameter for staging and monitoring the progression and response to therapy of prostate cancer.
64
The prostate gland increases in size with age; therefore, it is expected that older males will have higher PSA levels compared with younger males. PSA serum concentrations can also increase after prostatic manipulation such as digital rectal examination (DRE), catheter placement, transrectal ultrasound, cystoscopy, or biopsy of the prostate. In addition, serum PSA will increase 24 to 48 hours after ejaculation. Although elevated serum concentrations of PSA can occur in males with BPH, concentrations tend to be higher and encountered more often in males with cancer. Males with PSA levels between 4 and 10 ng/mL should be evaluated further for potential prostate cancer.
The serum half-life of PSA is 2 to 3 days, but serum PSA concentrations can remain high for several weeks after manipulation of the prostate. Circulating serum PSA is bound to plasma proteins, and the capability exists to measure both total and free (unbound) PSA concentrations. Increased risk of prostate cancer has been observed in males with a free PSA to total PSA ratio of <0.25.65 An
https://t.me/medicina_free
aggressive approach to localize prostate cancer for males with life expectancies >10 years is now favored.
64,66
Thyroid-Stimulating Hormone
Reference Range: 0.5–4.7 μIU/mL or mIU/L
Thyroid-stimulating hormone (TSH, also known as thyrotropin) is secreted by the pituitary gland to stimulate the thyroid gland to produce the thyroid hormones T4 and T3. TSH is measured, often in
conjunction with the thyroid hormones, to diagnose thyroid disorders and to monitor exogenous thyroid supplementation therapy. The reader is referred to Chapter 52, Thyroid Disorders, because it provides a more detailed discussion of the clinical implications of altered thyroid laboratory findings.
Procalcitonin
Procalcitonin is a precursor of calcitonin and is typically undetectable in healthy individuals. Elevations in procalcitonin occur in patients with inflammation secondary to bacterial infections; however, a similar increase is not observed in patients with inflammation secondary to viral infections or noninfectious conditions. Once there is a systemic inflammation due to bacterial infection, synthesis of procalcitonin will be induced in almost all tissues and then released into the blood.67 Interestingly, increases in calcitonin are not seen in patients with elevated procalcitonin. In patients with sepsis or sepsis syndrome, procalcitonin levels <0.5 ng/mL have been associated with a low risk of progression to severe sepsis, and levels >2.0 ng/mL represent a high risk for severe sepsis. Trials involving lower respiratory tract infections have suggested that antibiotic therapy should be discouraged in patients with procalcitonin levels <0.25 ng/mL but encouraged for those with levels ≥0.5 ng/mL. These criteria have also been used as a guide for discontinuing therapy as infections resolve; however, there are differences in how procalcitonin levels are managed among different institutions.
https://t.me/medicina_free
Additional further trials will help accurately define the role of procalcitonin testing.
Cholesterol and Triglycerides
A detailed discussion of hypercholesterolemia and lipid disorders is provided in Chapter 8, Dyslipidemias, Atherosclerosis, and Coronary Heart Disease. For convenience, the current range of desired values for total cholesterol (TC), low-density lipoproteins (LDLs), high­density lipoproteins (HDLs), and fasting TGs has been incorporated in Table 2-2.
HEMATOLOGY
There are several different hematologic cell types that originate from the hematopoietic stem cell. Each cell line has a defined role and unique contribution to the overall homeostatic process and may be found in the bone marrow, lymph system, or blood. Typically, routine clinical laboratory testing involves measuring concentrations of mature myeloid cells found in the blood. Figure 2-2 illustrates the various lineages derived from the hematopoietic stem cell.68 The cells derived from the myeloid linage are the focus of the following discussion. Readers are encouraged to refer to Section 16, Hematology and Oncology, to gain further understanding of the clinical relevance of lymphoid and myeloid cells (Fig. 2-2).
https://t.me/medicina_free
Figure 2-2 Hematopoietic stem cell lineage. MK, megakaryocyte;
EB, erythroblast. (Adapted with permission from Greer JP, Foerster
Bone
https://t.me/medicina_free
Marrow
Endothelial
cell
Hematopoietic
hematopoietic
Myeloid
progenitor
celt
stem
Committed
cell
progenitor
cell
Macrophage
Blood
(
Lymphoid
Organ
Fibroblast
]
Adipocyte
Monodendritic
progenitor
I
©
Monoblas
Monocyte
Monocyte
Macrophage
f
o
<
!
0
Dendritic
progenitor
o
Dendritic
cell
cell
Neutrophil
Eosinophil
cell
Granulocyte
monocyte
progenitor
cell
Promyelocyte
t
f
Myelocytes
f
© ® ®
Metamyelocytes
f
t
© ® ®
Band
granulocytes
Basophil
-
t
Plasma
1
1
1
S
<
Erythro
progenitor
Reticulocyte
Reticulocyte
)
Erythrocyte
'
cell
MK
-
cell
o
ProEB
I
©
Baso
I
0
Poly
I
Ortho
I
G
I
*
I
o
cs
EB
EB
EB
B
-
progenitor
>
MK
(S)
MK
MK
Ssf
Platelets
cell
blast
-
I
cyte
-
I
cyte
-
>
f
m
I I
m
Cell
B
I
1
m
T
Plasma
CS
progenitor
Cell
cell
cell
T
-
CM
>
m
Cell
T
m
T
Cell
C
B
O
Cell
B
-
r
J, Rodgers GM, et al, eds. Wintrobe’s Clinical Hematology. 12th ed. Lippincott Williams & Wilkins; 2009:80.)
Complete Blood Count
The complete blood count (CBC) is one of the most commonly ordered clinical laboratory tests. A CBC measures the RBCs, Hgb, hematocrit (Hct), platelets, mean cell volume (MCV), mean cell hemoglobin concentration (MCHC), mean platelet volume (MPV), and total WBCs. CBC with differential will measure all the values mentioned earlier; in addition, it will also measure the number of each type of WBCs. An abbreviated method of noting hematologic parameters in clinical practice is noted in the following figure.
Red Blood Cells (Erythrocytes)
Reference Range: Males, 4.3–5.9 × 106/μL or 4.3–5.9 × 1012/L Reference Range: Females, 3.5–5 × 106/μL or 3.5–5 × 1012/L
Erythrocytes or RBCs are produced in the bone marrow, released into the peripheral blood, circulated for ~120 days, and cleared by the reticuloendothelial system. The primary function of RBCs is to transport oxygen linked to Hgb from the lungs to tissues. The concentration of RBCs in the blood can be measured to detect anemia, calculate RBC indices, or calculate the Hct. Hct and Hgb concentrations are generally used to monitor quantitative changes in RBCs.
Hematocrit
Reference Range: Males, 40.7%–50.3% or 0.4–0.503 Reference Range: Females, 36%–44.6% or 0.36–0.446
https://t.me/medicina_free
(Eq. 2-9)
(Eq. 2-10)
Hct (packed cell volume) is the percentage of RBCs to the total blood volume and is determined by centrifuging a capillary tube of whole blood and comparing the height of the settled RBCs to the height of the column of whole blood. A decrease in Hct may result from bleeding, the bone marrow suppressant effects of drugs, chronic diseases, genetic alterations in RBC morphology, or hemolysis. An increase in Hct may result from hemoconcentration, polycythemia vera, or polycythemia secondary to chronic hypoxia.
Hemoglobin
Reference Range: Males, 13.8–17.5 g/dL or 138–175 g/L Reference Range: Females, 12.1–15.3 g/dL or 121–153 g/L
Hgb is the major oxygen-carrying compound contained in RBCs. Therefore, total Hgb concentration primarily depends on the number of RBCs in the blood sample. As mentioned with Hct, medical conditions that impact the number of RBCs will also affect Hgb concentration. As discussed previously, glycated Hgb (A1c) is a
related test used to monitor diabetes mellitus.
Red Blood Cell Indices
RBC indices (also known as Wintrobe indices) are useful in the classification of anemias. These indices include the MCV, the mean cell hemoglobin (MCH), and the MCHC. These indices are calculated in Eqs. 2-9 to 2-11:
https://t.me/medicina_free
(Eq. 2-11)
MEAN CELL VOLUME
The MCV detects changes in cell size. A decreased MCV indicates a microcytic cell, which can result from iron deficiency anemia or anemia of chronic inflammation. A large MCV indicates a macrocytic cell, which can be caused by a vitamin B12 or folic acid deficiency.
Underlying disease states (eg, habitual alcohol ingestion, chronic liver disease, anorexia nervosa, hypothyroidism, reticulocytosis, and hematologic disorders) may also present with an elevated MCV secondary to deficiencies in these vitamins.69 The MCV can be normal in a patient with a “mixed” (microcytic and macrocytic) anemia. Note that a direct assessment of a blood smear by a microscopic examination is the gold standard for confirming RBC size.
MEAN CELL HEMOGLOBIN
The MCHC is a more reliable index of RBC Hgb than is MCH. MCH measures the weight of Hgb in the RBCs in a sample, and MCHC measures the concentration of the RBCs contained within a sample. In normochromic anemias, changes in the size of RBCs (MCV) are associated with corresponding changes in the weight of Hgb (MCH), but the concentration of Hgb (MCHC) remains normal. Changes in the Hgb content of RBCs alter the color of these cells. Thus, hypochromic refers to a decrease in RBC Hgb, reflected by reduced MCHC, and may indicate iron deficiency anemia. Conversely, hyperchromic RBCs have an elevated MCHC because of the presence of greater amounts of Hgb. Hyperchromic cells are not commonly encountered.
Reticulocytes
Reference Range: Adults, 0.5%–1.5% of RBCs or 0.005–0.015
https://t.me/medicina_free
Reticulocytes are young, immature erythrocytes, and typically comprise about 1% of the RBCs. The reticulocyte count measures the percentage of these new cells in the circulating blood. An increase in the number of reticulocytes implies that an increased number of erythrocytes are being released into the blood in response to a stimulus. Reticulocyte count is a good indicator of bone marrow activity because it represents a recent production. Because erythrocytes regenerate rapidly, reticulocytosis can be noted within 3 to 5 days of hemolysis or after a hemorrhagic episode. Appropriate treatment of anemias caused by iron, vitamin B12, or folic acid
deficiencies should result in an increased reticulocyte count. Caution must be exercised in the interpretation of reticulocyte counts. Changes in the number of RBCs will result in proportional changes in the reticulocyte count because the latter is reported as a percentage of the number of RBCs.
Erythrocyte Sedimentation Rate
Reference Range: 0–30 mm/hour
The ESR is the rate (expressed in mm/hour) at which erythrocytes settle to the bottom of a test tube through the forces of gravity and in response to fibrinogen levels in the blood. The ESR is a nonspecific value and may be increased abnormally in acute and chronic inflammatory processes, acute and chronic infections, neoplasms, infarction, tissue necrosis, rheumatoid-collagen disease, dysproteinemias, nephritis, and pregnancy. However, ESR can also be affected by changes not related to the inflammation (eg, change in erythrocyte size, shape, or number). Laboratory technique can also affect the sedimentation rate substantially. Because many factors can enhance the settling rate of RBCs, moderate to marked elevation of the ESR merely indicates an inflammatory component to a disease state. An increased ESR in the setting of a normal physical examination is usually transient and is rarely the harbinger of serious occult disease.
70
https://t.me/medicina_free